Persian
Persian
English
Home
latest Achievements
About Us
Company Info
Honors
Certificates
Managers Introduction
Company Regulations
Partner Companies
Health Information
Products
Multidose Eye Drops
Strengthening eyelashes and eyebrows
Increased eye pressure and open-angle glaucoma
Antibiotics
Ophthalmic antihistamine
Corticosteroid
Artificial tear
Anticongestants
Anti Inflammatory
Nasal Sprays
Prefilled Syringes
HTK Solution R&D
media
Photo Gallery
34th Annual Congress of Ophthalmology 11-14 November 2025
Unveiling of HTK Solution for transplanted organs
The 31st Annual Seminar of the Ophthalmology Department of Shiraz University of Medical Sciences
The 30th Annual Seminar of the Ophthalmology Department of Shiraz University of Medical Sciences
The 30th Ophthalmology Farabi Annual Seminar
The 8th International Congress of the Iranian Rhinology Association
The Twenty-Ninth Farabi Annual Seminar
Drug Therapy Seminar for Non-Communicable Diseases for Pharmacists and General Practitioners
Ceremony to Honor selected Researchers and technologists of Fars Province
The Sixth Joint Meeting of Iran and Shahid Beheshti Universities of Medical Sciences
Educational Videos
Scientific Articles
News
News
Complaints
contact
Contact Info
Job Positions
Persian
Persian
English
Archive
Search Site :
Search Site
Rare Eye Complication in Paclitaxel Users — A Warning for Early Diagnosis
A new study shows that Paclitaxel, a drug used for the treatment of breast cancer, can, in very rare cases, cause a serious complication known as Central Retinal Artery Occlusion (CRAO)....
Under-Eye Rejuvenation With Hyaluronic Acid Filler
Under-Eye Rejuvenation With Hyaluronic Acid Filler: New Insights and the Role of Imaging
Meibomian Gland Dysfunction (MGD)
Meibomian Gland Dysfunction (MGD) Is Not Just an Elderly Disease
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
PolyActiva and RareSight have announced a “strategic collaboration” to develop first-in-class therapies for rare pediatric retinal diseases with no current approved drug treatments.
Exploring presbyopia progression in patients with glaucoma treated with PF receptor agonists:
Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience accelerated progression of presbyopia
Low-dose atropine causes esotropia in patient case
A 15-year-old boy developed myopia at 8 years and was treated with 0.01% atropine daily in both eyes. The atropine dose was increased yearly as the myopia progressed.
The search for drugs suitable for use with glaucoma drainage devices (GDDs) is ongoing:
The challenge is to identify drugs and associated substances that do not cause adverse effects or complications in pediatric patients with GDD implants.
EyeCool Therapeutics Announces Results of Pilot Study of Novel Chronic Ocular Surface Pain Treatment
Clinical-stage medical technology company EyeCool Therapeutics, based in Cambridge, Massachusetts, has announced positive results from a pilot study on its investigational ETX-4143 device for the treatment of chronic ocular surface pain (COSP).
Long-term Effects of COVID-19 on the Ocular Surface
A research team from Turkey, led by Dr. Oğuzhan Kılıçarslan (FEBO, FICO), has reported that COVID-19 affects the morphology of corneal endothelial cells in patients with ocular symptoms.